Cargando…
UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib
Anlotinib, as a promising oral small-molecule antitumor drug, its role in glioma has been only reported in a small number of case reports. Therefore, anlotinib has been considered as a promising candidate in glioma. The aim of this study was to investigate the metabolic network of C6 cells after exp...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192199/ https://www.ncbi.nlm.nih.gov/pubmed/37198251 http://dx.doi.org/10.1038/s41598-023-34902-5 |